Viewing Study NCT04358458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2025-12-29 @ 4:37 AM
Study NCT ID: NCT04358458
Status: TERMINATED
Last Update Posted: 2024-10-24
First Post: 2020-04-01
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
Sponsor: Genmab
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-cell Lymphoma View
None Follicular Lymphoma View
None Marginal Zone Lymphoma View
None Small Lymphocytic Lymphoma View
None Mantle Cell Lymphoma View
None Chronic Lymphocytic Leukemia View
None High-grade B-cell Lymphoma View
None Primary Mediastinal Large B-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anti-CD37, monoclonal antibodies, DuoHexabody® View